Basecamp Research raises $140 million to develop AI-designed therapeutics
Summary
Basecamp Research raises a $140 million Series C to train AI models for designing therapeutics, beginning with in vivo cell therapy, in a round led by S32 with Nvidia’s NVentures and Anthropic’s Anthology Fund participating.
Key Points
- London-based Basecamp Research raises a $140 million Series C led by S32, with Nvidia’s NVentures and Anthropic’s Anthology Fund participating.
- Basecamp plans to use the funding to train new AI models and advance AI-designed therapeutics, starting with in vivo cell therapy.
- Founded in 2019 by doctors Glen Gowers and Oliver Vince, Basecamp has raised $225 million total and trains models on a proprietary genomic dataset from partnerships in more than 30 countries.